Indians Bought 1.2 Cr ‘Controversial’ anti-Covid Molnupiravir Pills for Rs 50 Cr in First Month of Launch
Despite concerns over the safety of anti-Covid drug molnupiravir, Indians have purchased around 1.2 crore pills worth Rs 50 crore […]
Despite concerns over the safety of anti-Covid drug molnupiravir, Indians have purchased around 1.2 crore pills worth Rs 50 crore […]
Eight capsules of molnupiravir are taken orally for five days, for a total of 40 capsules.Washington: Merck’s anti-Covid pill remains
The Central government hasn’t included antiviral drug Molnupiravir in its revised clinical guidance for management of adult COVID-19 patients, and
Read more ICMR chief Dr Balram Bhargav flagged concerns about antiviral Molnupiravir. The Maharashtra government on Monday issued a letter
As Omicron continues to drive Covid cases in India, the Ministry of health and welfare has issued a slew of
The conflict of opinion between the country’s apex medical research body ICMR and drug regulator DCGI has divided the medical
The UK MHRA on December 4 granted approval for Molnupiravir under special condition for treatment of mild to moderate COVID-19
A total of 60 lakh Covishield and 40 lakh Covaxin doses are among a list of demands by the Maharashtra
India’s COVID-19 vaccination coverage crossed 153.7 crore on Tuesday with 76,68,282 vaccine doses being administered till 7 p.m., the Union
The United Kingdom is set to roll out another trial to generate more data on the benefits and side effects
The National National Task Force for COVID-19 of ICMR has made the decision to not include the antiviral drug Molnupiravir
A majority of Covid patients during this Omicron-driven surge of infections have so far shown mild symptoms that can be